Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 1998

View Archived Issues

Abbott synthesizes a novel series of cyclic antifungal agents

Akzo Nobel describes new gonadotropins with therapeutic potential

Alcon discloses new antiglaucoma agents in patent literature

New antifungals from Lilly

New anticoagulants reported by Berlex

Canadian researchers design new cysteine protease inhibitors

Anti-MRSA agents prepared at Bristol-Myers Squibb

Warner-Lambert describes water-soluble, nonpeptide ET antagonists

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Avakine submitted for FDA review

CIMA terminates one and initiates another OraSolv agreement

VX-740 advances in preclinical studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...